Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study
2016 ◽
Vol 36
(3)
◽
pp. 734-739
◽
Benoit Peyronnet
◽
Evelyne Castel-Lacanal
◽
Mathieu Roumiguie
◽
Lucie Even
◽
Philippe Marque
◽
...